Generic Drug Product Development - Bioequivalence Issues (Hardcover)

The assessment of bioequivalence is an important process whereby the bioavailability of a generic drug product is compared with its brand-name counterpart. Generic pharmaceutical products must be approved as therapeutic equivalents to the brand name alternative in order to be interchangeable. The demonstration of bioequivalence is an important component of therapeutic equivalence. Bioequivalence studies are very expensive, time consuming and always have the possibility of failure. The objective of this textbook is to describe some of those specific bioequivalence issues which need to be considered for the design and conduct of bioequivalence studies. By exploring scientific, legal, and international regulatory challenges, Generic Drug Development, discusses the use of alternative approaches to the measurement of plasma drug concentrations for the demonstration of bioequivalence, and covers bioequivalence procedures for drug products that are not easily assessed - based upon the physical and chemical properties of the active drug and the nature of the drug product.

General

Imprint:	Crc Press
Country of origin:	United States
Release date:	November 2007
First published:	2007
Authors:	Isadore Kanfer • Leon Shargel
Dimensions:	229 x 152 x 19mm (L x W x T)
Format:	Hardcover
Pages:	288
ISBN-13:	978-0-8493-7784-6
Categories:	Books > Business & Economics > Industry & industrial studies > Manufacturing industries > Pharmaceutical industries Books > Professional & Technical > Industrial chemistry & manufacturing technologies > Industrial chemistry > Pharmaceutical technology
LSN:	0-8493-7784-6
Barcode:	9780849377846

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!